Clinical Trial

Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update

Breakthrough in Delivering Chimeric Bait Receptors to Immune Cells Accelerates Development LONDON, UK / ACCESSWIRE / December 6, 2024 /…

3 weeks ago

Myant and Coapt Partner to Transform Assistive Technology and Pain Management with Textile-Based Neural Interfaces

TORONTO, Dec. 5, 2024 /PRNewswire/ -- Myant Corp., a pioneer in textile computing for healthcare, and Coapt, a leader in…

3 weeks ago

Stemtech Corporation / Viago and Eevia Health Announce Proposed RTO

NAPLES, FL / ACCESSWIRE / December 5, 2024 / Stemtech Corporation (OTCQB:STEK), a US-based company announced this past Tuesday its…

3 weeks ago

IceCure’s ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results

Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors < 3 cm and a safe…

3 weeks ago

Lungpacer Medical Announces Premarket Approval for AeroPace® System

AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy for quicker patient liberation from mechanical ventilationEXTON, Pa., Dec. 05,…

3 weeks ago

Vanqua Bio to Present Pre-Clinical Data on VQ-201, a Next Generation C5aR1 Antagonist for the Treatment of Inflammatory Disorders

CHICAGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present at…

3 weeks ago

Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISSCollaboration Aims to Enhance Healthspan on Earth and Improve Astronaut…

3 weeks ago

Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group

Pooled data analysis of efficacy and safety from Phase 2b and Phase 3 data sets in patients with early-stage Parkinson’s…

3 weeks ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

First-in-class catheter-based sensing technology designed to sense neuronal signals that indicate pain or disease and destroy those nerves at the…

3 weeks ago